Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ALFACELL CORP | 540 000 | déclaré | 23 juil. 2012 | tx 11+1 203 750−5 000 |
| EPICEPT CORP | 21 699 | déclaré | 08 janv. 2015 | tx 13+216 713 |
| CHAMPIONS ONCOLOGY, INC. | 21 216 | déclaré | 05 nov. 2025 | tx 29+4 917 412−238 662 |
| Business Outsourcing Service, Inc. | 20 450 | déclaré | 20 déc. 2023 | tx 13+189 026 |
| IMCLONE SYSTEMS INC/DE |
| 18 750 |
| déclaré |
| 18 janv. 2006 |
| tx 10+128 434 |
| ZILA INC | 16 000 | déclaré | 09 janv. 2007 | tx 3+46 000 |
| Advaxis, Inc. | 2 342 | déclaré | 19 janv. 2023 | tx 21+320 898−22 808 |
| Ayala Pharmaceuticals, Inc. | 0 | déclaré | 19 janv. 2023 | tx 13+25 250−25 250 |
| KV PHARMACEUTICAL CO /DE/ | 0 | déclaré | 16 sept. 2013 | tx 10+65 000−58 500 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 05 nov. 2025 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 21 216 | 6.80 USD | deriv |
| 12 nov. 2024 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 21 880 | 4.64 USD | deriv |
| 20 déc. 2023 | GRANT_AWARD | Business Outsourcing Service, Inc. | 20 450 | 0.00 USD | deriv |
| 03 nov. 2023 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 15 495 | 5.51 USD | deriv |
| 01 nov. 2022 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 11 480 | 7.00 USD | deriv |
| 19 janv. 2023 | GRANT_AWARD | Advaxis, Inc. | 46 | — | |
| 19 janv. 2023 | GRANT_AWARD | Advaxis, Inc. | 2 342 | — | deriv |
| 19 janv. 2023 | GRANT_AWARD | Advaxis, Inc. | 2 342 | — | deriv |
| 19 janv. 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 250 | — | |
| 19 janv. 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 12 500 | — | deriv |
| 19 janv. 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 12 500 | — | deriv |
| 23 déc. 2022 | GRANT_AWARD | Business Outsourcing Service, Inc. | 20 450 | 0.00 USD | deriv |
| 12 oct. 2022 | EXERCISE | CHAMPIONS ONCOLOGY, INC. | 8 333 | 3.21 USD | |
| 12 oct. 2022 | TAX_WITHHOLDING | CHAMPIONS ONCOLOGY, INC. | 3 562 | 7.51 USD | |
| 12 oct. 2022 | EXERCISE | CHAMPIONS ONCOLOGY, INC. | 8 333 | 0.00 USD | deriv |
| 13 juin 2022 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 12 500 | 0.00 USD | deriv |
| 16 déc. 2021 | GRANT_AWARD | Business Outsourcing Service, Inc. | 2 045 | 0.00 USD | deriv |
| 05 nov. 2021 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 8 045 | 10.10 USD | deriv |
| 15 oct. 2021 | EXERCISE | CHAMPIONS ONCOLOGY, INC. | 16 667 | 1.59 USD | |
| 15 oct. 2021 | TAX_WITHHOLDING | CHAMPIONS ONCOLOGY, INC. | 2 629 | 10.08 USD | |
| 15 oct. 2021 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 16 667 | 0.00 USD | deriv |
| 10 juin 2021 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 12 500 | 0.00 USD | deriv |
| 14 août 2020 | PURCHASE | Ayala Pharmaceuticals, Inc. | 5 | 11.07 USD | |
| 11 sept. 2020 | PURCHASE | Ayala Pharmaceuticals, Inc. | 10 | 10.07 USD | |
| 08 mai 2020 | PURCHASE | Ayala Pharmaceuticals, Inc. | 200 | 15.27 USD |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 07 mai 2020.